A Bioavailability Study of FL-101 in Healthy Male and Female Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This will be a single-center, randomized, open-label, single dose, parallel study to assess the absolute bioavailability of FL-101 when administered via the subcutaneous (SC) and intravenous (IV) routes.
Epistemonikos ID: c2bcdac10184c88fed06a2d9dae374200f800cba
First added on: May 09, 2024